Abstract
In his first delineation of the concept of dementia praecox at the end of the nineteenth century, Emil Kraepelin proposed the existence of progressive degenerative neuronal changes underlying the symptoms of this disorder, soon later renamed as schizophrenia by Eugen Bleuler (see review by DeLisi, 2008). On the basis of Kraepelin’s writings, a number of authors have, over several decades, formulated theories proposing that schizophrenia should be seen as a neurodegenerative disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Addington, J., Chaves, A. & Addington, D. Diagnostic stability over one year in first-episode psychosis. Schizophrenia Research 86(1–3): 71–75, 2006.
Agartz, I., Sedvall, G.C., Terenius, L., Kulle, B., Frigessi, A., Hall, H. & Jönsson, E.G. BDNF gene variants and brain morphology in schizophrenia. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 141B(5): 513–523, 2006.
Allen, L.S. & Gorski, R.A. Sexual dimorphism of the anterior commissure and massa intermedia of the human brain. Journal of Comparative Neurology 312(1): 97–104, 1991.
Arnold, S.E. & Rioux, L. Challenges, status, and opportunities for studying developmental neuropathology in adult schizophrenia. Schizophrenia Bulletin 27(3): 395–416, 2001.
Arnold, S.E., Trojanowski, J.Q., Gur, R.E., Blackwell, P., Han, L.Y, Choi, C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Archives of General Psychiatry 55(3): 225–232, 1998.
Bachmann, S., Bottmer, C., Pantel, J., Schröder, J., Amann, M., Essig, M. & Schad, L.R. MRI-morphometric changes in first-episode schizophrenic patients at 14 months follow-up. Schizophrenia Research 67(2–3): 301–303, 2004.
Bartzokis, G. Schizophrenia: Breakdown in the well regulated lifelong process of brain development and maturation. Neuropsychopharmacology 27(4): 672–683, 2002.
Bogerts, B. The neuropathology of schizophrenic diseases: historical aspects and present knowledge. European Archives of Psychiatry and Clinical Neuroscience 249 (Suppl 4): 2–13, 1999.
Borgwardt, S.J., McGuire, P.K., Aston, J., Gscwandtener, U., Pflüger, M., Stielitz, R., Radue, E., Riecher-Rössler, A. Reductions of the frontal, temporal and parietal volume associated with the onset of psychosis. Schizophrenia Research 106: 108–114, 2008.
Borgwardt, S.J., Riecher-Rössler A., Dazzan, P., Chitnis, X., Aston, J. Drewe, M., Gschwandtner, U., Haller, S., Pflüger, M., Rechsteiner, E., D´Souza, M., Sieglitz, R.D., Radü, E.W., McGuire P.K., Regional gray matter volume abnormalities in the at risk mental state. Biological Psychiatry 61(10): 1148–1156, 2007.
Brisch, R., Bernstein, H.G., Krell, D., Stauch, R., Trübner, K., Dobrowolny, H., Kropf, S., Bielau, H., Bogerts, B. Volumetric analysis of septal region in schizophrenia and affective disorder. European Archives of Psychiatry and Clinical Neuroscience 257(3): 140–148, 2007.
Buckley, P.F., Mahadik, S., Pillai, A., Terry, A. Neurotrophins and schizophrenia. Schizophrenia Research 94(1–3): 1–11, 2007.
Bustillo, J.R., Lauriello, J., Rowland, L.M., Thomson, L.M., Petropoulos, H., Hammond, R., Hart, B. & Brooks, W.M. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure. Schizophrenia Research 58(2–3): 313–321, 2002.
Cahn, W., Hulshoff Pol, H.E., Bongers, M., Schnack, H.G., Mandl, R.C., Van Haren, N.E., Durston, S., Koning, H., Van Der Linden, J.A. & Kahn, R.S. Brain morphology in antipsychotic-naïve schizophrenia: a study of multiple brain structures. British Journal of Psychiatry 43(Suppl): s66–s72, 2002.
Cahn, W., Hulshoff Pol, H.E., Lems, E.B., Van Haren, N.E., Schnack, H.G., Van Der Linden, J.A., Schothorst, P.F., Van Engeland, H. & Kahn, R.S. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Archives of General Psychiatry 59(11): 1002–1010, 2002.
Carpenter, M.B. & Sutin, J. Human Neuroanatomy (8th ed.). Williams & Wilkins, Baltimore, pp. 52–54, 1983.
Chakos, M.H., Lieberman, J.A., Alvir, J., Bilder, R. & Ashtari, M. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet 345(8947): 456–457, 1995.
Chakos, M.H., Lieberman, J.A., Bilder, R.M., Borenstein, M., Lerner, G., Bogerts, B., Wu, H., Kinon, B. & Ashtari, M. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. American Journal of Psychiatry 151(10): 1430–1436, 1994.
Chakos, M.H., Schobel, S.A., Gu, H., Gerig, G., Bradford, D., Charles, C. & Lieberman, J.A. Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. British Journal of Psychiatry 186: 26–31, 2005.
Chen, Y., Dubé, C.M., Rice, C.J., Baram, T.Z. Rapid loss of dendritic spines after stress involves derangement of spine dynamics by corticotropin-releasing hormone. Journal of Neuroscience 28(11): 2903–2911, 2008.
Cheung, V., Cheung, C., McAlonan, G.M., Deng, Y., Wong, J.G., Yip, L., Tai, K.S., Khong, P.L., Sham, P. & Chua, S.E. A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia. Psychological Medicine 38(6): 877–885, 2008.
Crespo-Facorro, B., Roiz-Santiáñez, R., Pérez-Iglesias, R., Pelayo-Terán, J.M., Rodríguez-Sánchez, J.M., Tordesillas-Gutiérrez, D., Ramírez, M., Martínez, O., Gutiérrez, A., De Lucas, E.M. & Vázquez-Barquero, J.L. Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Progress in Neuropsychopharmacology & Biological Psychiatry 32(8): 1936–1943, 2008.
Davis, C.E., Jeste, D.V. & Eyler, L.T. Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia. Schizophrenia Research 78(1): 45–60, 2005.
Davis, K.L., Stewart, D.G., Friedman, J.I., Buchsbaum, M., Harvey, P.D., Hof, P.R., Buxbaum, J., Haroutunian, V. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archives of General Psychiatry 60(5): 443–456, 2003.
Dazzan, P., Morgan, K.D., Orr, K., Hutchinson, G., Chitnis, X., Suckling, J., Fearon, P., McGuire, P.K., Mallett, R.M., Jones, P.B., Leff, J. & Murray, R.M. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology 30: 765–774, 2005.
De Souza Crippa, J.A., Zuardi, A.W., Busatto, G.F., Sanches, R.F., Santos, A.C., Araújo, D., Amaro, E., Hallak, J.E., Ng, V. & McGuire, P.K. Cavum septum pellucidum and adhesio interthalamica in schizophrenia: an MRI study. European Psychiatry 21(5): 291–299, 2006.
DeLisi, LE. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophrenia Research 23(2): 119–129, 1997.
DeLisi, L.E. The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. Schizophrenia Bulletin 34(2): 312–321, 2008.
DeLisi, L.E. & Hoff, A.L. Failure to find progressive temporal lobe volume decreases 10 years subsequent to a first episode of schizophrenia. Psychiatry Research 138(3): 265–268, 2005.
DeLisi, L.E., Hoff, A.L., Kushner, M. & Degreef, G. Increased prevalence of cavum septum pellucidum in schizophrenia. Psychiatry Research 50(3): 193–199, 1993.
DeLisi, L.E., Sakuma, M., Maurizio, A.M., Relja, M. & Hoff, A.L. Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Research 130(1): 57–70, 2004.
DeLisi, L.E., Sakuma, M., Tew, W., Kushner, M., Hoff, A.L. & Grimson, R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Research 74(3): 129–140, 1997.
Dickey, C.C., McCarley, R.W., Xu, M.L., Seidman, L.J., Voglmaier, M.M., Niznikiewicz, M.A., Connor, E. & Shenton, M.E. MRI abnormalities of the hippocampus and cavum septi pellucidi in females with schizotypal personality disorder. Schizophrenia Research 89(1–3): 49–58, 2007.
Dickey, C.C., Salisbury, D.F., Nagy, A.I., Hirayasu, Y., Lee, C.U., McCarley, R.W. & Shenton, M.E. Follow-up MRI study of prefrontal volumes in first-episode psychotic patients. Schizophrenia Research 71(2–3): 349–351, 2004.
Ellison-Wright, I. & Bullmore, E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophrenia Research 108(1–3): 3–10, 2009.
Ellison-Wright, I., Glahn, D.C., Laird, A.R., Thelen, S.M. & Bullmore, E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. American Journal of Psychiatry 165: 1015–1023, 2008.
Ettinger, U., Picchioni, M., Landau, S., Matsumoto, K., Van Haren, N.E., Marshall, N., Hall, M.H., Schulze, K., Toulopoulou, T., Davies, N., Ribchester, T., McGuire, P.K. & Murray, R.M. Magnetic resonance imaging of the thalamus and adhesio interthalamica in twins with schizophrenia. Archives of General Psychiatry 64(4): 401–409, 2007.
Filipović, B., Kovacević, S., Stojicić, M., Prostran, M. & Filipović, B. Morphological differences among cavum septi pellucidi obtained in patients with schizophrenia and healthy individuals: forensic implications. A post-mortem study. Psychiatry and Clinical Neurosciences 59(1): 106–108, 2005.
Flashman, L.A., Roth, R.M., Pixley, H.S., Cleavinger, H.B., Mcallister, T.W., Vidaver, R. & Saykin, A.J. Cavum septum pellucidum in schizophrenia: clinical and neuropsychological correlates. Psychiatry Research 154(2): 147–155, 2007.
Friedman, J.I., Tang, C., Carpenter, D., Buchsbaum, M., Schmeider, J., Flanagan, L., Golembo, S., Kanellopoulo, I., Ng, J., Hof, P.R., Harvey, P.D., Tsopelas, N.D., Stewart, D., Davis, K.L. Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. American Journal of Psychiatry 165(8): 1024–1032, 2008.
Fukuzako, H. & Kodama, S. Cavum septum pellucidum in schizophrenia. Biological Psychiatry 43(6): 467, 1998.
Galarza, M., Merlo, A.B., Ingratta, A., Albanese, E.F. & Albanese, A.M. Cavum septum pellucidum and its increased prevalence in schizophrenia: a neuroembryological classification. Journal of Neuropsychiatry and Clinical Neurosciences 16(1): 41–46, 2004.
Glantz, L.A, Gilmore, J.H., Lieberman, J.A. & Jarskoq, L.F. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophrenia Research 81(1): 47–63, 2006.
Good, C.D., Johnsrude, I.S., Ashburner, J., Henson, R.N., Friston, K.J. & Frackowiak, R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14: 21–36, 2001.
Gregório, S.P., Sallet, P.C., Do, K.A., Lin, E., Gattaz, W.F. & Dias-Neto, E. Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: preliminary evidence. Psychiatry Research 165(1–2): 1–9, 2009.
Gruber, O., Falkai, P., Schneider-Axmann, T., Schwab, S.G., Wagner, M. & Maier, W. Neuregulin-1 haplotype HAP(ICE) is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members. Journal of Psychiatric Research 43(1): 1–6, 2008.
Gur, R.E., Cowell, P., Turetsky, B.I., Gallacher, F., Cannon, T., Bilker, W. & Gur R.C. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Archives of General Psychiatry 55(2): 145–152, 1998.
Gur, R.E., Keshavan, M.S. & Lawrie, S.M. Deconstructing psychosis with human brain imaging. Schizophrenia Bulletin 33: 921–931, 2007.
Haahr, U., Friis, S., Larsen, T.K., Melle, I., Johannessen, J.O., Opjordsmoen, S., Simonsen, E., Rund, B.R., Vaglum, P. & Mcglashan, T. First-episode psychosis: diagnostic stability over one and two years. Psychopathology 41(5): 322–329, 2008.
Hagino, H., Suzuki, M., Kurokawa, K., Mori, K., Nohara, S., Takahashi, T., Yamashita, I., Yotsutsuji, T., Kurachi, M. & Seto, H. Magnetic resonance imaging study of the cavum septi pellucidi in patients with schizophrenia. American Journal of Psychiatry 158(10): 1717–1719, 2001.
Harris, J.M., Moorhead, T.W., Miller, P., Mcintosh, A.M., Bonnici, H.M., Owens, D.G., Johnstone, E.C. & Lawrie, S.M. Increased prefrontal gyrification in a large high-risk cohort characterizes those who develop schizophrenia and reflects abnormal prefrontal development. Biological Psychiatry 62(7): 722–729, 2007.
Harrison, P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122(4): 593–624, 1999.
Harrison, P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174(1): 151–162, 2004.
Harrison, P.J. & Weinberger, D.R. Schizophrenia genes, gene expression and neuropathology: on the matter of their convergence. Molecular Psychiatry 10(1): 40–68, 2005.
Ho, B.C., Andreasen, N.C., Dawson, J.D. & Wassink, T.H. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. American Journal of Psychiatry 164(12): 1890–1899, 2007.
Ho, B.C., Andreasen, N.C., Nopoulos, P., Arndt, S., Magnotta, V. & Flaum, M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Archives of General Psychiatry 60(6): 585–594, 2003.
Ho, B.C., Milev, P., O’leary, D.S., Librant, A., Andreasen, N.C. & Wassink, T.H. Cognitive and magnetic resonance imaging brain morphometric correlates of brain derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Archives of General Psychiatry 63(7): 731–740, 2006.
Honea, R., Crow, T.J., Passingham, D. & Mackay, C.E. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. American Journal of Psychiatry 162(12): 2233–2245, 2005.
Hopper, K. & Wanderling, J. Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative followup project. International Study of Schizophrenia. Schizophrenia Bulletin 26(4): 835–846, 2000.
Hulshoff Pol, H.E. & Kahn, R.S. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophrenia Bulletin 34(2): 354–366, 2008.
Jessen, F., Scherk, H., Träber, F., Theyson, S., Berning, J., Tepest, R., Falkai, P., Schild, H.H., Maier, W., Wagner, M. & Block, W. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia. Schizophrenia Research 87(1–3): 81–88, 2006.
Job, D.E., Whalley, H.C., Johnstone, E.C. & Lawrie, S.M. Grey matter changes over time in high risk subjects developing schizophrenia. NeuroImage 25: 1023–1030, 2005.
Job, D.E., Whallety, H.C., McConnell, S., Glabus, M. Johnstone, E.C. & Lawrie, S.M. Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. NeuroImage 17(2): 880–889, 2002.
Job, D.E., Whalley, H.C., McConnell, S., Glabus, M., Johnstone, E.C. & Lawrie, S.M. Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia. Schizophrenia Research 64(1): 1–13, 2003.
Jones, D.K. Studying connections in the living human brain with diffusion MRI. Cortex 44: 936–952, 2008.
Kasai, K., Iwanami, A., Yamasue, H., Kuroki, N., Nakagome, K. & Fukuda, M. Neuroanatomy and neurophysiology in schizophrenia. Neuroscience Research 43(2): 93–110, 2002.
Kasai, K., McCarley, R.W., Salisbury, D.F., et al. Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study. Schizophrenia Research 71(1): 65–76, 2004.
Kasai, K., Shenton, M.E., Salisbury, D.F., Hirayasu, Y., Lee, C.U., Ciszewski, A.A., Yurgelun-Todd, D., Kikinis, R., Jolesz, F.A. & McCarley, R.W. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. American Journal of Psychiatry 160(1): 156–164, 2003b.
Kasai, K., Shenton, M.E., Salisbury, D.F., Hirayasu, Y., Onitsuka, T., Spencer, M.H., Yurgelun-Todd, D.A., Kikinis, R., Jolesz, F.A. & McCarley, R.W. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Archives of General Psychiatry 60(8): 766–775, 2003a.
Keshavan, M.S. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. Journal of Psychiatry Research 33(6): 513–521, 1999.
Keshavan, M.S., Anderson, S. & Pettegrew, J.W. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. Journal of Psychiatry Research 28(3): 239–265, 1994.
Keshavan, M.S., Bagwell, W.W., Haas, G.L., Sweeney, J.A., Schooler, N.R. & Pettegrew, J.W. Changes in caudate volume with neuroleptic treatment. Lancet 344(8934): 1434, 1994.
Keshavan, M.S., Haas, G.L., Kahn, C.E., Aguilar, E., Dick, E.L., Schooler, N.R., Sweeney, J.A. & Pettegrew, J.W. Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? Journal of Psychiatry Research 32(3–4): 161–167, 1998.
Keshavan, M.S., Stanley, J.A. & Pettegrew, J.W. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings – part II. Biological Psychiatry 48(5): 369–380, 2000.
Khorram, B., Lang, D.J., Kopala, L.C., Vandorpe, R.A., Rui, Q., Goghari, V.M., Smith, G.N. & Honer, W.G. Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. American Journal of Psychiatry 163(11): 2005–2007, 2006.
Konopaske, G.T., Dorph-Petersen, K.A., Pierri, J.N., Wu, Q., Sampson, A.R. & Lewis, D.A. Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 32(6): 1216–1223, 2007.
Konopaske, G.T., Dorph-Petersen, K.A., Sweet, R.A., Pierri, J.N., Zhang, W., Sampson, A.R. & Lewis, D.A. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biological Psychiatry 63(8): 759–765, 2008.
Konrad, A. & Winterer, G. Disturbed structural connectivity in schizophrenia – primary factor in pathology or epiphenomenon? Schizophrenia Bulletin 34(1): 72–92, 2008.
Koo, M.S., Levitt, J.J., Salisbury, D.F., Nakamura, M., Shenton, M.E. & McCarley, R.W. A cross-sectional and longitudinal magnetic resonance imaging study of cingulated gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Archives of General Psychiatry 65(7): 746–760, 2008.
Kuhnley, E.J., White, D.H. & Granoff, A.L. Psychiatric presentation of an arachnoid cyst. Journal of Clinical Psychiatry 42(4): 167–168, 1981.
Kwon, J.S., Shenton, M.E., Hirayasu, Y., Salisbury, D.F., Fischer, I.A., Dickey, C.C., Yurgelun-Todd, D., Tohen, M., Kikinis, R., Jolesz, F.A. & McCarley, R.W. MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder. American Journal of Psychiatry 155(4): 509–515, 1998.
Kyriakopoulos, M., Bargiotas, T., Barker, G.J. & Frangou, S. Diffusion tensor imaging in schizophrenia. European Psychiatry 23(4): 255–273, 2008.
Lawrie, S.M., Mcintosh, A.M., Hall, J., Owens, D.G. & Johnstone, E.C. Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. Schizophrenia Bulletin 34(2): 330–340, 2008.
Lawrie, S.M., Whalley, H.C., Abukmeil, S.S., Kestelman, J.N., Donnelly, L., Miller, P., Best, J.J., Owens, D.G. & Johnstone, E.C. Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia. Biological Psychiatry 49(10): 811–823, 2001.
Lee, W., Bindman, J., Ford, T., Glozier, N., Moran, P., Stewart, R. & Hotopf, M. Bias in psychiatric case–control studies: literature survey. British Journal of Psychiatry 190: 204–209, 2007.
Lencz T., Cornblatt, B. & Bilder, R.M. Neurodevelopmental models of schizophrenia: pathophysiologic synthesis and directions for intervention research. Psychopharmacology Bulletin 35(1): 95–125, 2001.
Lewis, D.A. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 16(6): 385–398, 1997.
Lewis, S.W., Reveley, M.A., David, A.S. & Ron, M.A. Agenesis of the corpus callosum and schizophrenia: a case report. Psychological Medicine 18(2): 341–347, 1988.
Lieberman, J., Chakos, M., Wu, H., Alvir, J., Hoffman, E., Robinson, D. & Bilder, R. Longitudinal study of brain morphology in first episode schizophrenia. Biological Psychiatry 49(6): 487–499, 2001.
Lieberman, J.A., Tollefson, G.D., Charles, C., Zipursky, R., Sharma, T., Kahn, R.S., Keefe, R.S., Green, A.I., Gur, R.E., Mcevoy, J., Perkins, D., Hamer, R.M., Gu, H. & Tohen, M.; HGDH Study Group. Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry 62(4): 361–370, 2005.
Malobabic, S., Puskas, L. & Blagotic, M. Size and position of the human adhaesio interthalamica. Gegenbaurs Morphologisches Jahrbuch 133(1): 175–180, 1987.
Mata, I., Perez-Iglesias, R., Roiz-Santiañez, R., Tordesillas-Gutierrez, D., Gonzalez-Mandly, A., Vazquez-Barquero, J.L. & Crespo-Facorro, B. A neuregulin 1 variant is associated with increased lateral ventricle volume in patients with first-episode schizophrenia. Biological Psychiatry 65(6): 535–540, 2009.
McClure, R.K., Carew, K., Greeter, S., Maushauer, E., Steen, G. & Weinberger, D.R. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment. Schizophrenia Research 98(1–3): 29–39, 2008.
Mcintosh, A.M., Maniega, S.M., Lymer, G.K., Mckirdy, J., Hall, J., Sussmann, J.E., Bastin, M.E., Clayden, J.D., Johnstone, E.C. & Lawrie, S.M. White matter tractography in bipolar disorder and schizophrenia. Biological Psychiatry 64(12): 1088–1092, 2008.
Meisenzahl, E.M., Frodl, T., Zetzsche, T., Leinsinger, G., Heiss, D., Maag, K., Hegerl, U., Hahn, K. & Möller, H.J. Adhesio interthalamica in male patients with schizophrenia. American Journal of Psychiatry 157(5): 823–825, 2000.
Meisenzahl, E.M., Frodl, T., Zetzsche, T., Leinsinger, G., Maag, K., Hegerl, U., Hahn, K. & Möller, H.J. Investigation of a possible diencephalic pathology in schizophrenia. Psychiatry Research 115(3): 127–135, 2002.
Molina, V., Reig, S., Sanz, J., Palomo, T., Benito, C., Sánchez, J., Pascau, J. & Desco, M. Changes in cortical volume with olanzapine in chronic schizophrenia. Pharmacopsychiatry 40(4): 135–139, 2007.
Morgan, K.D., Dazzan, P., Orr, K.G., Hutchinson, G., Chitnis, X., Suckling, J., Lythgoe, D., Pollock, S.J., Rossell, S., Shapleske, J., Fearon, P., Morgan, C., David, A., McGuire, P.K., Jones, P.B., Leff, J. & Murray, R.M. Grey matter abnormalities in first-episode schizophrenia and affective psychosis. British Journal of Psychiatry Supplement 51: s111–s116, 2007.
Murray, R.M. & Fearon, P. The developmental “risk factor” model of schizophrenia. Journal of Psychiatry Research 33(6): 497–499, 1999.
Murray, R.M. & Lewis, S.W. Is schizophrenia a neurodevelopmental disorder? British Medical Journal 295(6600): 681–682, 1987.
Nakamura, M., Salisbury, D.F., Hirayasu, Y., Bouix, S., Pohl, K.M., Yoshida, T., Koo, M.S., Shenton, M.E. & McCarley, R.W. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biological Psychiatry 62(7): 773–783, 2007.
Nopoulos, P., Krie, A. & Andreasen, N.C. Enlarged cavum septi pellucidi in patients with schizophrenia: clinical and cognitive correlates. Journal of Neuropsychiatry and Clinical Neurosciences 12(3): 344–349, 2000.
Nopoulos, P., Swayze, V. & Andreasen, N.C. Pattern of brain morphology in patients with schizophrenia and large cavum septi pellucidi. Journal of Neuropsychiatry and Clinical Neurosciences 8(2): 147–152, 1996.
Nopoulos, P., Swayze, V., Flaum, M., Ehrhardt, J.C., Yuh, W.T. & Andreasen, N.C. Cavum septi pellucidi in normals and patients with schizophrenia as detected by magnetic resonance imaging, Biological Psychiatry 41(11): 1102–1108, 1997.
Nopoulos, P.C., Giedd, J.N., Andreasen, N.C. & Rapoport, J.L. Frequency and severity of enlarged cavum septi pellucidi in childhood-onset schizophrenia. American Journal of Psychiatry 155(8): 1074–1079, 1998.
Nopoulos, P.C., Rideout, D., Crespo-Facorro, B. & Andreasen, N.C. Sex differences in the absence of massa intermedia in patients with schizophrenia versus healthy controls. Schizophrenia Research 48(2–3): 177–185, 2001.
Panenka, W.J., Khorram, B., Barr, A.M., Smith, G.N., Lang, D.J., Kopala, L.C., Vandorpe, R.A. & Honer, W.G. A longitudinal study on the effects of typical versus atypical antipsychotic drugs on hippocampal volume in schizophrenia. Schizophrenia Research 94(1–3): 288–292, 2007.
Pantelis, C., Velakoulis, D., McGorry, P.D., Wood, S.J., Suckling, J., Philips, L.J., Yung, A.R., Bullmore, E.T, Brewer, W., Soulsby, B., Desmond, P. & McGuire, P.K. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361: 281–288, 2003.
Pantelis, C., Yücel, M., Wood, S.J., Velakoulis, D., Sun, D., Berger, G., Stuart, G.W., Yung, A., Phillips, L. & McGorry, P.D. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophrenia Bulletin 31(3): 672–696, 2005.
Peters, B.D., de Haan, L., Dekker, N., Blaas, J., Becker, H.E., Dingemans, P.M., Akkerman, E.M., Majoie, C.B., Van Ameslvoort, T., Den Heeten, G.J. & Linzen, D.H. White matter fibertracking in first-episode schizophrenia, schizoaffective patients and subjects at ultra-high risk of psychosis. Neuropsychobiology 58(1): 19–28, 2008.
Price, G., Bagary, M.S., Cercignani, M., Altmann, D.R. & Ron, M.A. The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study. Journal of Neurology, Neurosurgery and Psychiatry 76(4): 585–587, 2005.
Price, G., Cercignani, M., Bagary, M.S., Barnes, T.R., Barker, G.J., Joyce, E.M. & Ron, M.A. A volumetric MRI and magnetization transfer imaging follow-up study of patients with first-episode schizophrenia. Schizophrenia Research 87(1–3): 100–108, 2006.
Price, G., Cercignani, M., Parker, G.J., Altmann, D.R., Barnes, T.R., Barker, G.J., Joyce, E.M. & Ron, M.A. Abnormal brain connectivity in first-episode psychosis: a diffusion MRI tractography study of the corpus callosum. NeuroImage 35(2): 458–466, 2007.
Price, G., Cercignani, M., Parker, G.J., Altmann D.R, Barnes, T.R. Barker, G.J. Joyce, E.M. & Ron, M.A. White matter tracts in first-episode psychosis: a DTI tractography study of the uncinate fasciculus. Neuroimage 39(3): 949–955, 2008.
Puri, B.K., Hutton, S.B., Saeed, N., Oatridge, A., Hajnal, J.V., Duncan, L., Chapman, M.J., Barnes, T.R., Bydder, G.M. & Joyce, E.M. A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration. Psychiatry Research 106(2): 141–150, 2001.
Rajarethinam, R., Miedler, J., DeQuardo, J., Smet, C.I., Brunberg, J., Kirbat, R., Tandon, R. Prevalence of cavum septum pellucidum in schizophrenia studied with MRI. Schizophrenia Research 48(2–3): 201–205, 2001.
Rajarethinam, R., Sohi, J., Arfken, C. & Keshavan, M.S. No difference in the prevalence of cavum septum pellucidum (CSP) between first-episode schizophrenia patients, offspring of schizophrenia patients and healthy controls. Schizophrenia Research 103(1–3): 22–25, 2008.
Rakic, P. & Yakovlev, P.I. Development of the corpus callosum and cavum septi in man. Journal of Comparative Neurology 132(1): 45–72, 1968.
Reveley, A.M. & Reveley, M.A. Aqueduct stenosis and schizophrenia. Journal of Neurology, Neurosurgery and Psychiatry 46(1): 18–22, 1983.
Rosales, R.K., Lemay, M.J. & Yakovlev, P.I. The development and involution of massa intermedia with regard to age and sex. Journal of Neuropathology & Experimental Neurology 27(1): 166, 1968.
Saijo, T., Abe, T., Someya, Y., Sassa, T., Sudo, Y., Suhara, T., Shuno, T., Asai, K. & Okubo, Y. Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study. Psychiatry and Clinical Neuroscience 55(1): 41–47, 2001.
Sallet, P.C., Elkis, H., Alves, T.M., Oliveira, J.R., Sassi, E., Campi DE Castro, C., Busatto, G.F. & Gattaz WF. Reduced cortical folding in schizophrenia: an MRI morphometric study. American Journal of Psychiatry 160(9): 1606–1613, 2003.
Schaufelberger M.S., Duran F.L. Lappin, J.M. Scazufca M. Amaro, E. JR., Leite, C.C., de Castro C.C., Murray, R.M., McGuire P.K., Menezes, P.R. & Busatto, G.F. Grey matter abnormalities in Brazilians with first-episode psychosis. British Journal of Psychiatry Supplement 51: s117–s122, 2007.
Schaufelberger, M.S., Lappin, J.M., Duran, F.L.S., Rosa, P.G.P., Uchida, R.R., Santos, L.C., Murray, R.M., McGuire, P.K., Scazufca, M., Menezes, P.R. & Busatto, G.F. Lack of progression of brain abnormalities in first-episode psychosis: a longitudinal MRI study over 15 months. Submitted for publication.
Scheepers, F.E., De Wied, C.C., Hulshoff Pol, H.E., Van De, F.W., Van Der Linden, J.A. & Kahn, R.S. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. Neuropsychopharmacology 24(1): 47–54, 2001.
Schlagenhauf, F., Wüstenberg, T., Schmack, K., Dinges, M., Wrase, J., Koslowski, M., Kienast, T., Bauer, M., Gallinat, J., Juckel, G. & Heinz, A. Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory. European Neuropsychopharmacology 18(8): 589–599, 2008.
Selemon, L.D. & Goldman-Rakic, P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biological Psychiatry 45(1): 17–25, 1999.
Shenton, M.E., Dickey, C.C., Frumin, M. & McCarley, R.W. A review of MRI findings in schizophrenia. Schizophrenia Research 49(1–2): 1–52, 2001.
Shunk H. Congenital dilatations of the septi pellucidum. Radiology 81: 610–618, 1963.
Snyder, P.J., Bogerts, B., Wu, H., Bilder, R.M., Deoras, K.S. & Lieberman, J.A. Absence of the adhesio interthalamica as a marker of early developmental neuropathology in schizophrenia: an MRI and postmortem histologic study. Journal of Neuroimaging 8(3): 159–163, 1998.
Steen, R.G., Mull, C., McClure R., Hamer R.M. & Lieberman, J.A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. British Journal of Psychiatry 188: 510–518, 2006.
Sun, D., Phillips, L., Velakoulis, D., Yung, A., McGorry, P.D., Wood, S.J., Van Erp, T.G., Thompson, P.M., Toga, A.W., Cannon, T.D. & Pantelis, C. Progressive brain structural changes mapped as psychosis develops in “at risk” individuals. Schizophrenia Research 108(1–3): 85–92, 2009.
Sun, D., Stuart, G.W., Jenkinson, M., Wood, S.J., McGorry, P.D., Velakoulis, D., Van Erp, T.G., Thompson, P.M., Toga, A.W., Smith, D.J., Cannon, T.D. & Pantelis, C. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Molecular Psychiatry 14(10): 976–986, 2009.
Szeszko, P.R., Lipsky, R., Mentschel, C., Robinson, D., Gunduz-Bruce, H., Sevy, S., Ashtari, M., Napolitano, B., Bilder, R.M., Kane, J.M., Goldman, D. & Malhotra, A.K. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Molecular Psychiatry 10(7): 631–636, 2005.
Takahashi, T., Suzuki, M., Hagino, H., Niu, L., Zhou, S.Y., Nakamura, K., Tanino, R., Kawasaki, Y., Seto, H. & Karachi, M. Prevalence of large cavum septi pellucidi and its relation to the medial temporal lobe structures in schizophrenia spectrum. Progress in Neuropsychopharmacology & Biological Psychiatry 31(6): 1235–1241, 2007.
Takahashi, T., Suzuki, M., Nakamura, K., Tanino, R., Zhou, S.Y., Hagino, H., Niu, L., Kawasaki, Y., Seto, H. & Kurachi, M. Association between absence of the adhesio interthalamica and amygdala volume in schizophrenia. Psychiatry Research 162(2): 101–111, 2008.
Takahashi, T., Wood, S.J., Yung, A.R., Phillips, L.J., Soulsby, B., McGorry, P.D., Tanino, R., Zhou, S.Y., Suzuki, M., Velakoulis, D. & Pantelis, C. Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis. Schizophrenia Research 111(1–3): 94–102, 2009.
Takahashi, T., Wood, S.J., Yung, A.R., Soulsby, B., McGorry, P.D., Suzuki, M., Kawasaki, Y., Phillips, L.J., Velakoulis, D. & Pantelis, C. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Archives of General Psychiatry 66(4): 366–376, 2009.
Tan, H.Y., Nicodemus, K.K., Chen, Q., Li, Z., Brooke, J.K., Honea, R., Kolachana, B.S., Straub, R.E., Meyer-Lindenberg, A., Sei, Y., Mattay, V.S., Callicott, J.H. & Weinberger, D.R. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. Journal of Clinical Investigations 118(6): 2200–2208, 2008.
Terry, A.V. Jr., Gearhart, D.A., Warner, S., Hohnadel, E.J., Middlemore, M.L., Zhang, G., Bartlett, M.G. & Mahadik, S.P. Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in rats. Neuroscience 150(2): 413–424, 2007b.
Terry, A.V. Jr., Gearhart, D.A., Warner, S.E., Zhang, G., Bartlett, M.G., Middlemore, M.L., Beck, W.D. Jr., Mahadik, S.P. & Waller, J.L. Oral haloperidol or risperidone treatment in rats: temporal effects on nerve growth factor receptors, cholinergic neurons, and memory performance. Neuroscience 146(3): 1316–1332, 2007a.
Théberge, J., Williamson, K.E., Aoyama, N., Drost, D.J., Manchanda, R., Malla, A.K., Northcott, S., Menon, R.S., Neufeld, R.W., Rajakumar, N., Pavlosky, W., Densmore, M., Schaefer, B. & Williamson, P.C. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia. British Journal of Psychiatry 191: 325–334, 2007.
Thompson, P.M., Bartzokis, G., Hayashi, K.M., Klunder, A.D., Lu, P.H., Edwards, N., Hong, M.S., Yu, M., Geaga, J.A., Toga, A.W., Charles, C., Perkins, D.O., Mcevoy, J., Hamer, R.M., Tohen, M., Tollefson, G.D., Lieberman, J.A. & the HGDH Study Group. Time-lapse mapping of cortical changes in schizophrenia with different treatments. Cerebral Cortex 19(5): 1107–1123, 2009
Tsuang, M.T., Stone, W.S. & Faraone, S.V. Genes, environment and schizophrenia. British Journal of Psychiatry Supplement 40: s18–s24, 2001.
Uematsu, M. & Kaiya, H. Midsagittal cortical pathomorphology of schizophrenia: a magnetic resonance imaging study. Psychiatry Research 30(1): 11–20, 1989.
Van Haren, N.E., Cahn, W., Hulshoff Pol, H.E. & Kahn RS. Schizophrenia as a progressive brain disease. European Psychiatry 23(4): 245–254, 2008a.
Van Haren, N.E., Hulshoff Pol, H.E., Schnack, H.G., Cahn, W., Brans, R., Carati, I., Rais, M. & Kahn RS. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biological Psychiatry 63(1): 106–113, 2008b.
Van Haren, N.E., Hulshoff Pol, H.E., Schnack, H.G., Cahn, W., Mandl, R.C., Collins, D.L., Evans, A.C. & Kahn, R.S. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology 32(10): 2057–2066, 2007.
Varnäs, K., Lawyer, G., Jönsson, E.G., Kulle, B., Nesvåg, R., Hall, H., Terenius, L. & Agartz, I. Brain-derived neurotrophic factor polymorphisms and frontal cortex morphology in schizophrenia. Psychiatric Genetics 18(4): 177–183, 2008.
Vita A., De Peri, L., Silenzi, C. & Dieci, M. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophrenia Research 82(1): 75–88, 2006.
Wacholder, S. Design issues in case–control studies. Statistical Methods in Medical Research 4: 293–309, 1995.
Waddington, J.L., Lane, A., Scully, P.J., Larkin, C. & O´Callaghan, E. Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary over a lifetime trajectory of disease? Psychiatry Clinics of North America 21(1): 123–149, 1998.
Wang, L., Mamah, D., Harms, M.P., Karnik, M., Price, J.L., Gado, M.H., Thompson, P.A., Barch, D.M., Miller, M.I. & Csernansky, J.G. Progressive deformation of deep brain nuclei and hippocampal–amygdala formation in schizophrenia. Biological Psychiatry 64(12): 1060–1068, 2008.
Weinberger, D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 44(7): 660–669, 1987.
Westmoreland Corson, P.W., Nopoulos, P., Miller, D.D., Arndt, S. & Andreasen, N.C. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. American Journal of Psychiatry 156(8): 1200–1204, 1999.
Whitford, T.J., Farrow, T.F., Rennie, C.J., Grieve, S.M., Gomes, L., Brennan, J., Harris, A.W. & Williams, L.M. Longitudinal changes in neuroanatomy and neural activity in early schizophrenia. Neuroreport 18(5): 435–439, 2007a.
Whitford, T.J., Grieve, S.M., Farrow, T.F., Gomes, L., Brennan, J., Harris, A.W., Gordon, E. & Williams, L.M. Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. American Journal of Psychiatry 164(7): 1082–1089, 2007b.
Whitworth, A.B., Kemmler, G., Honeder, M., Kremser, C., Felber, S., Hausmann, A., Walch, T., Wanko, C., Weiss, E.M., Stuppaeck, C.H. & Fleischhacker, W.W. Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients. Psychiatry Research 140(3): 225–237, 2005.
Wood, S.J., Pantelis, C., Velakoulis, D., Yucel, M., Fornito, A., McGorry, P.D. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophrenia Bulletin 34(2): 322–329, 2008.
Wood, S.J., Velakoulis, D., Smith, D.J., Bond, D., Stuart, G.W., McGorry, P.D., Brewer, W.J., Bridle, N., Eritaia, J., Desmond, P., Singh, B., Copolov, D. & Pantelis, C. A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophrenia Research 52(1–2): 37–46, 2001.
Woods, B.T. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. American Journal of Psychiatry 155(12): 1661–1670, 1998.
Wright, I.C., Rabe-Hesketh, S., Woodruff, P.W., David, A.S., Murray, R.M. & Bullmore, E.T. Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry 157(1): 16–25, 2000.
Yoon, U., Lee, J.M., Kwon, J.S., Kim, H.P., Shin, Y.W., Ha, T.H., Kim, I.Y., Chang, K.H. & Kim, S.I. An MRI study of structural variations in schizophrenia using deformation field morphometry. Psychiatry Research 146(2): 171–177, 2006.
Zipursky, R.B., Christensen, B.K. & Mikulis, D.J. Stable deficits in gray matter volumes following a first episode of schizophrenia. Schizophrenia Research 71(2–3): 515–516, 2004.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Busatto, G.F., Zanetti, M.V., Schaufelberger, M.S., Crippa, J.A. (2010). Brain Anatomical Abnormalities in Schizophrenia: Neurodevelopmental Origins and Patterns of Progression over Time. In: Gattaz, W., Busatto, G. (eds) Advances in Schizophrenia Research 2009. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0913-8_6
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0913-8_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0912-1
Online ISBN: 978-1-4419-0913-8
eBook Packages: MedicineMedicine (R0)